Zilla P, Fullard L, Trescony P, Meinhart J, Bezuidenhout D, Gorlitzer M, Human P, von Oppell U
Department of Cardiothoracic Surgery, University of Cape Town, South Africa.
J Heart Valve Dis. 1997 Sep;6(5):510-20.
Due to its superb crosslinking activity, glutaraldehyde (GA) is still the most widely used fixative for bioprosthetic heart valves. At the same time, however, GA is also believed to be partly responsible for tissue calcification and the lack of surface re-endothelialization, both of which may contribute to valve degeneration. Although excess GA has previously been extracted from thin leaflet tissue, this treatment proved insufficient for the detoxification of thick aortic wall tissue of stentless valves or root prostheses.
In order to establish a detoxification procedure which thoroughly extracts biologically active GA from aortic wall tissue, we used a highly sensitive bioassay where endothelial cells were seeded onto glutaraldehyde-fixed aortic wall discs following various detoxification procedures. Absolute cell numbers and morphologic shape were correlated with shrinkage temperature and shrinkage extent of the tissue to determine the potential of the treatments to reverse crosslinks. To optimize treatment conditions, pH (3.2 versus 4.5), temperature (22 degrees C versus 37 degrees C) and incubation time (48 h versus one week) were varied. In order to identify an optimal detoxification agent, 12 different amino-reagents from four chemical groups were compared: low pKa aromatic amines, amino acids, low pKa N-heterocyclic compounds and amino sugars.
Amino-reagent treatment required warm temperature (37 degrees C), prolonged reaction time (one week) and a pH of 4.5 to achieve long-term cell growth on glutaraldehyde-fixed aortic wall. All 12 amino-reagents were able to detoxify aortic tissue satisfactorily; and all mildly reversed crosslinks, although there were differences between candidates. When summarized data were ranked correlating cell growth and quality with shrinkage temperature and shrinkage extent, seven reagents had a rank sum above the overall mean value, and five below with statistically significant differences between candidates. The additional stabilization of the detoxification reaction through borohydride-reduction had no further effect on tissue biocompatibility and crosslinks.
Efficient detoxification of thick aortic wall tissue is possible if a one-week incubation in an acetic acid buffer-based amino-reagent is carried out at 37 degrees C.
由于戊二醛(GA)具有出色的交联活性,它仍是生物人工心脏瓣膜最广泛使用的固定剂。然而,与此同时,GA也被认为是组织钙化和缺乏表面再内皮化的部分原因,这两者都可能导致瓣膜退变。尽管之前已从薄瓣叶组织中提取出过量的GA,但该处理方法被证明对于无支架瓣膜或根部假体的厚主动脉壁组织的解毒并不充分。
为了建立一种能从主动脉壁组织中彻底提取生物活性GA的解毒程序,我们使用了一种高灵敏度生物测定法,即在各种解毒程序后,将内皮细胞接种到戊二醛固定的主动脉壁圆盘上。绝对细胞数量和形态与组织的收缩温度和收缩程度相关,以确定处理方法逆转交联的潜力。为了优化处理条件,改变了pH值(3.2对4.5)、温度(22℃对37℃)和孵育时间(48小时对一周)。为了确定最佳解毒剂,比较了来自四个化学组的12种不同的氨基试剂:低pKa芳香胺、氨基酸、低pKa氮杂环化合物和氨基糖。
氨基试剂处理需要温暖的温度(37℃)、延长的反应时间(一周)和pH值为4.5,才能在戊二醛固定的主动脉壁上实现长期细胞生长。所有12种氨基试剂都能令人满意地使主动脉组织解毒;并且都能轻度逆转交联,尽管候选试剂之间存在差异。当将与细胞生长和质量相关的数据按收缩温度和收缩程度进行排名汇总时,7种试剂的秩和高于总体平均值,5种低于总体平均值,候选试剂之间存在统计学显著差异。通过硼氢化物还原对解毒反应进行额外稳定处理对组织生物相容性和交联没有进一步影响。
如果在37℃下在基于乙酸缓冲液的氨基试剂中孵育一周,则厚主动脉壁组织的有效解毒是可能的。